Reaction
No Adverse Effect reporting signals
As of the last recalculation, No Adverse Effect appears in 1,802 FAERS reports alongside 5 co-occurring drug terms. The strongest observed disproportionality signal is ISOTRETINOIN (PRR 509.6).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Isotretinoin | 988 | 509.6 | 520.0 |
| Thalidomide | 57 | 18.5 | 18.5 |
| Raloxifene Hydrochloride | 9 | 7.2 | 7.2 |
| Cetuximab | 16 | 5.9 | 5.9 |
| Exenatide | 17 | 3.8 | 3.8 |